Telomerase expression in amyotrophic lateral sclerosis (ALS) patients

Journal of Human Genetics

Volumn 59, Issue 10, 2014, Pages 555-561

  De Felice, Bruna ^a   Annunziata, Anna ^b   Fiorentino, Giuseppe ^b   Manfellotto, Francesco ^a   D'Alessandro, Raffaella ^a   Marino, Rita ^c   Borra, Marco ^c   Biffali, Elio ^c  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b MONALDI HOSPITAL   (Italy)

^c STAZIONE ZOOLOGICA ANTON DOHRN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROTEIN P21; PROTEIN P53; TELOMERASE; HRAS PROTEIN, HUMAN; TERT PROTEIN, HUMAN; TP53 PROTEIN, HUMAN;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN TISSUE; LEUKOCYTE; MALE; NERVE DEGENERATION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SPINAL CORD; TELOMERE; AGED; BLOOD; CEREBROSPINAL FLUID; ENZYMOLOGY; GENE EXPRESSION; GENETICS; METABOLISM; MIDDLE AGED;

AGED; AMYOTROPHIC LATERAL SCLEROSIS; FEMALE; GENE EXPRESSION; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS P21(RAS); TELOMERASE; TELOMERE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84908476792     PISSN: 14345161     EISSN: 1435232X     Source Type: Journal    
DOI: 10.1038/jhg.2014.72     Document Type: Article

References (36)

1. Nakamura, T. M., Morin, G. B., Chapman, K. B., Weinrich, S. L., Andrews, W. H., Lingner, J. et al. Telomerase catalytic subunit homologs from fission yeast and human. Science 277, 955-959 (1997).
2. Blasco, M. A. Telomeres and human disease: ageing, cancer and beyond. Nat. Rev. Genet. 6, 611-622 (2005).
3. Yoo, J., Park, S. Y., Kang, S. J., Kim, B. K., Shim, S. I. & Kang, C. S. Expression of telomerase activity, human telomerase RNA, and telomerase reverse transcriptase in gastric adenocarcinomas. Mod. Pathol. 16, 700-707 (2003).
4. Vogelstein, B., Lane, D. & Levine, A. J. Surfing the p53 network. Nature 408, 307-310 (2000).
5. Kusumoto, M., Ogawa, T., Mizumoto, K., Ueno, H., Niiyama, H., Sato, N. et al. Adenovirus-mediated p53 gene transduction inhibits telomerase activity independent of its effects on cell cycle arrest and apoptosis in human pancreatic cancer cells. Clin. Cancer Res. 5, 2140-2147 (1999).
6. Beausejour, C. M., Krtolica, A., Galimi, F., Narita, M., Lowe, S. W., Yaswen, P. et al. Reversal of human cellular senescence: roles of the p53 and p16 pathways. EMBO J. 22, 4212-4222 (2003).
7. Tao, Q., Lv, B., Qiao, B., Zheng, C. Q. & Chen, Z. F. Immortalization of ameloblastoma cells via reactivation of telomerase function: phenotypic and molecular characteristics. Oral Oncol. 45, 239-244 (2009).
8. Liu, X., Dakic, A., Chen, R., Disbrow, G. L., Zhang, Y., Dai, Y. et al. Cell-restricted immortalization by human papillomavirus correlates with telomerase activation and engagement of the hTERT promoter by Myc. J. Virol. 82, 11568-11576 (2008).
9. Haferkamp, S., Tran, S. L., Becker, T. M., Scurr, L. L., Kefford, R. F. & Rizos, H. The relative contributions of the p53 and pRb pathways in oncogene induced melanocyte senescence. Aging (Albany, NY) 1, 542-556 (2009).
10. Ohtani, N., Yamakoshi, K., Takahashi, A. & Hara, E. Realtime in vivo imaging of p16Ink4a gene expression: a new approach to study senescence stress signaling in living animals. Cell. Div. 5, 1 (2010).
11. Zhou, J., Ding, D., Wang, M. & Cong, Y. S. Telomerase reverse transcriptase in the regulation of gene expression. BMB Rep. 47, 8-14 (2014).
12. Ly, H. Genetic and environmental factors influencing human diseases with telomere dysfunction. Int. J. Clin. Exp. Med. 2, 114-130 (2009).
13. Nelson, N. D. & Bertuch, A. A. Dyskeratosis congenita as a disorder of telomere maintenance. Mutat. Res. 730, 43-51 (2012).
14. Jaskelioff, M., Muller, F. L., Paik, J. H., Thomas, E., Jiang, S., Adams, A. C. et al. Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice. Nature 469, 102-106 (2011).
15. Zhu, H., Fu, W. & Mattson, M. P. The catalytic subunit of telomerase protects neurons against amyloid beta-peptide-induced apoptosis. J. Neurochem. 75, 117-124 (2000).
16. De Felice, B., Guida, M., Guida, M., Coppola, C., De Mieri, G. & Cotrufo, R. A. miRNA signature in leukocytes from sporadic amyotrophic lateral sclerosis. Gene 508, 35-40 (2012).
17. Tichon, A., Gowda, B. K., Slavin, S., Gazit, A. & Priel, E. Telomerase activity and expression in adult human mesenchymal stem cells derived from amyotrophic lateral sclerosis individuals. Cytotherapy 11, 837-848 (2009).
18. Bissels, U., Wild, S., Tomiuk, S., Holste, A., Hafner, M., Tuschl, T. et al. Absolute quantification of microRNAs by using a universal reference. RNA 15, 2375-2384 (2009).
19. Cawthon, R. M. Telomere measurement by quantitative PCR. Nucleic Acids Res. 30, e47 (2002).
20. Eitan, E., Tichon, A., Daniel, G. & Priel, E. Telomerase expression in adult and old mouse Purkinje neurons. Rejuvenat. Res. 15, 206-209 (2012).
21. Niu, C. & Yip, H. K. Neuroprotective signaling mechanisms of telomerase are regulated by brain-derived neurotrophic factor in rat spinal cord motor neurons. J. Neuropathol. Exp. Neurol. 70, 634-652 (2011).
22. Lu, C., Fu, W. & Mattson, M. P. Telomerase protects developing neurons against DNA damage-induced cell death. Brain Res. Dev. Brain Res. 131, 167-171 (2001).
23. Kang, H. J., Choi, Y. S., Hong, S. B., Kim, K. W., Woo, R. S., Won, S. J. et al. Ectopic expression of the catalytic subunit of telomerase protects against brain injury resulting from ischemia and NMDA-induced neurotoxicity. J. Neurosci. 24, 1280-1287 (2004).
24. Fu, W., Begley, J. G., Killen, M. W. & Mattson, M. P. Anti-apoptotic role of telomerase in pheochromocytoma cells. J. Biol. Chem. 274, 7264-7271 (1999).
25. Li, J., Tang, B., Qu, Y. & Mu, D. Telomerase reverse transcriptase: a novel neuroprotective mechanism involved in neonatal hypoxic-ischemic brain injury. Int. J. Dev. Neurosci. 29, 867-872 (2011).
26. Fu, W., Killen, M., Pandita, T. & Mattson, M. P. The catalytic subunit of telomerase is expressed in developing brain neurons and serves a cell survival-promoting function. J. Mol. Neurosci. 14, 3-15 (2000).
27. Li, H., Cao, Y., Berndt, M. C., Funder, J. W. & Liu, J. P. Molecular interactions between telomerase and the tumor suppressor protein p53 in vitro. Oncogene 18, 6785-6794 (1999).
28. Plesnila, N., von Baumgarten, L., Retiounskaia, M., Engel, D., Ardeshiri, A., Zimmermann, R. et al. Delayed neuronal death after brain trauma involves p53-dependent inhibition of NF-kappaB transcriptional activity. Cell Death Differ. 14, 1529-1541 (2007).
29. Yamaguchi, A, Taniguchi, M, Hori, O, Ogawa, S, Tojo, N, Matsuoka, N et al. Peg3/Pw1 is involved in p53-mediated cell death pathway in brain ischemia/hypoxia. J. Biol. Chem. 277, 623-629 (2002).
30. Martin, L. J. p53 is abnormally elevated and active in the CNS of patients with amyotrophic lateral sclerosis. Neurobiol. Dis. 7(6 Pt B), 613-622 (2000).
31. Ranganathan, S. & Bowser, R. p53 and cell cycle proteins participate in spinal motor neuron cell death in ALS. Open Pathol. J. 4, 11-22 (2010).
32. Shats, I., Milyavsky, M., Tang, X., Stambolsky, P., Erez, N., Brosh, R. et al. p53-dependent down-regulation of telomerase is mediated by p21waf1. J. Biol. Chem. 279, 50976-50985 (2004).
33. Nelson, N. D. & Bertuch, A. A. Dyskeratosis congenita as a disorder of telomere maintenance. Mutat. Res. 730, 43-51 (2012).
34. Thomas, P., O'Callaghan, N. J. & Fenech, M. Telomere length in white blood cells, buccal cells and brain tissue and its variation with ageing and Alzheimer's disease. Mech. Ageing Dev. 129, 183-190 (2008).
35. Ahmed, S., Passos, J. F., Birket, M. J., Beckmann, T., Brings, S., Peters, H. et al. Telomerase does not counteract telomere shortening but protects mitochondrial function under oxidative stress. J. Cell Sci. 121(Pt 7), 1046-1053.
36. Eitan, E., Tichon, A., Gazit, A., Gitler, D., Slavin, S. & Priel, E. Novel telomerase increasing compound in mouse brain delays the onset of amyotrophic lateral sclerosis. EMBO Mol. Med. 4, 313-329 (2012).